Gross and microscopic changes of liver neoplasms and background hepatic structures following neoadjuvant therapy

Anjelica Hodgson, Zuhoor Almansouri, Oyedele Adeyi, Sandra E. Fischer

Research output: Contribution to journalArticle

Abstract

Liver transplantation is a surgical option with curative intent used in the management of some cases of hepatocellular carcinoma and cholangiocarcinoma (hilar, rarely intrahepatic). A number of different therapeutic modalities including ablative techniques, arterially directed therapies, radiation and chemotherapy are used in the neoadjuvant setting prior to liver transplantation with the goals of preventing tumour progression, decreasing post-transplant recurrence and possibly downstaging patients with tumour burden beyond what is acceptable by current transplant criteria. Pathologists evaluating hepatic explants must be aware of these neoadjuvant therapies and the alterations induced by them in both tumourous and non-tumourous tissue. In this review, we discuss common neoadjuvant therapies used in in this setting, as well as the gross and microscopic changes induced by these presurgical treatments within hepatic neoplasms as well as the background hepatic parenchyma and nearby structures. Select secondary tumours involving the liver which are pretreated will also be discussed. Finally, proper reporting of these changes will be mentioned.

Original languageEnglish (US)
Pages (from-to)112-119
Number of pages8
JournalJournal of Clinical Pathology
Volume72
Issue number2
DOIs
StatePublished - Feb 1 2019
Externally publishedYes

Fingerprint

Neoadjuvant Therapy
Liver Neoplasms
Liver Transplantation
Liver
Klatskin Tumor
Transplants
Case Management
Tumor Burden
Hepatocellular Carcinoma
Neoplasms
Radiotherapy
Recurrence
Drug Therapy
Therapeutics

Keywords

  • cholangiocarcinoma
  • hepatocellular carcinoma
  • liver metastases
  • neoadjuvant therapy
  • transplantation

PubMed: MeSH publication types

  • Journal Article
  • Review

Cite this

Gross and microscopic changes of liver neoplasms and background hepatic structures following neoadjuvant therapy. / Hodgson, Anjelica; Almansouri, Zuhoor; Adeyi, Oyedele; Fischer, Sandra E.

In: Journal of Clinical Pathology, Vol. 72, No. 2, 01.02.2019, p. 112-119.

Research output: Contribution to journalArticle

@article{01cb95e024594b40a067f7b1e841135a,
title = "Gross and microscopic changes of liver neoplasms and background hepatic structures following neoadjuvant therapy",
abstract = "Liver transplantation is a surgical option with curative intent used in the management of some cases of hepatocellular carcinoma and cholangiocarcinoma (hilar, rarely intrahepatic). A number of different therapeutic modalities including ablative techniques, arterially directed therapies, radiation and chemotherapy are used in the neoadjuvant setting prior to liver transplantation with the goals of preventing tumour progression, decreasing post-transplant recurrence and possibly downstaging patients with tumour burden beyond what is acceptable by current transplant criteria. Pathologists evaluating hepatic explants must be aware of these neoadjuvant therapies and the alterations induced by them in both tumourous and non-tumourous tissue. In this review, we discuss common neoadjuvant therapies used in in this setting, as well as the gross and microscopic changes induced by these presurgical treatments within hepatic neoplasms as well as the background hepatic parenchyma and nearby structures. Select secondary tumours involving the liver which are pretreated will also be discussed. Finally, proper reporting of these changes will be mentioned.",
keywords = "cholangiocarcinoma, hepatocellular carcinoma, liver metastases, neoadjuvant therapy, transplantation",
author = "Anjelica Hodgson and Zuhoor Almansouri and Oyedele Adeyi and Fischer, {Sandra E.}",
year = "2019",
month = "2",
day = "1",
doi = "10.1136/jclinpath-2018-205596",
language = "English (US)",
volume = "72",
pages = "112--119",
journal = "Journal of Clinical Pathology - Clinical Molecular Pathology",
issn = "0021-9746",
publisher = "BMJ Publishing Group",
number = "2",

}

TY - JOUR

T1 - Gross and microscopic changes of liver neoplasms and background hepatic structures following neoadjuvant therapy

AU - Hodgson, Anjelica

AU - Almansouri, Zuhoor

AU - Adeyi, Oyedele

AU - Fischer, Sandra E.

PY - 2019/2/1

Y1 - 2019/2/1

N2 - Liver transplantation is a surgical option with curative intent used in the management of some cases of hepatocellular carcinoma and cholangiocarcinoma (hilar, rarely intrahepatic). A number of different therapeutic modalities including ablative techniques, arterially directed therapies, radiation and chemotherapy are used in the neoadjuvant setting prior to liver transplantation with the goals of preventing tumour progression, decreasing post-transplant recurrence and possibly downstaging patients with tumour burden beyond what is acceptable by current transplant criteria. Pathologists evaluating hepatic explants must be aware of these neoadjuvant therapies and the alterations induced by them in both tumourous and non-tumourous tissue. In this review, we discuss common neoadjuvant therapies used in in this setting, as well as the gross and microscopic changes induced by these presurgical treatments within hepatic neoplasms as well as the background hepatic parenchyma and nearby structures. Select secondary tumours involving the liver which are pretreated will also be discussed. Finally, proper reporting of these changes will be mentioned.

AB - Liver transplantation is a surgical option with curative intent used in the management of some cases of hepatocellular carcinoma and cholangiocarcinoma (hilar, rarely intrahepatic). A number of different therapeutic modalities including ablative techniques, arterially directed therapies, radiation and chemotherapy are used in the neoadjuvant setting prior to liver transplantation with the goals of preventing tumour progression, decreasing post-transplant recurrence and possibly downstaging patients with tumour burden beyond what is acceptable by current transplant criteria. Pathologists evaluating hepatic explants must be aware of these neoadjuvant therapies and the alterations induced by them in both tumourous and non-tumourous tissue. In this review, we discuss common neoadjuvant therapies used in in this setting, as well as the gross and microscopic changes induced by these presurgical treatments within hepatic neoplasms as well as the background hepatic parenchyma and nearby structures. Select secondary tumours involving the liver which are pretreated will also be discussed. Finally, proper reporting of these changes will be mentioned.

KW - cholangiocarcinoma

KW - hepatocellular carcinoma

KW - liver metastases

KW - neoadjuvant therapy

KW - transplantation

UR - http://www.scopus.com/inward/record.url?scp=85060379521&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060379521&partnerID=8YFLogxK

U2 - 10.1136/jclinpath-2018-205596

DO - 10.1136/jclinpath-2018-205596

M3 - Article

C2 - 30670563

AN - SCOPUS:85060379521

VL - 72

SP - 112

EP - 119

JO - Journal of Clinical Pathology - Clinical Molecular Pathology

JF - Journal of Clinical Pathology - Clinical Molecular Pathology

SN - 0021-9746

IS - 2

ER -